DE122007000007I1
(de)
*
|
1986-04-09 |
2007-05-16 |
Genzyme Corp |
Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
|
US5366894A
(en)
*
|
1986-06-30 |
1994-11-22 |
Pharmaceutical Proteins Limited |
Peptide production
|
EP0832981A1
(de)
*
|
1987-02-17 |
1998-04-01 |
Pharming B.V. |
DNA-Sequenzen die Proteine zwecks effizienter Abscheidung zur Milchdrüse leiten
|
US6054566A
(en)
*
|
1988-02-26 |
2000-04-25 |
Biosource Technologies, Inc. |
Recombinant animal viral nucleic acids
|
US5316931A
(en)
*
|
1988-02-26 |
1994-05-31 |
Biosource Genetics Corp. |
Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
|
US6284492B1
(en)
*
|
1988-02-26 |
2001-09-04 |
Large Scale Biology Corporation |
Recombinant animal viral nucleic acids
|
US20030150019A1
(en)
*
|
1988-02-26 |
2003-08-07 |
Large Scale Biology Corporation |
Monopartite RNA virus transformation vectors
|
US5997859A
(en)
*
|
1988-03-21 |
1999-12-07 |
Chiron Corporation |
Method for treating a metastatic carcinoma using a conditionally lethal gene
|
US6020015A
(en)
*
|
1988-09-22 |
2000-02-01 |
Gaull; Gerald E. |
Infant formula compositions and nutrition containing genetically engineered human milk proteins
|
GB8823869D0
(en)
*
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
US5650503A
(en)
*
|
1988-11-11 |
1997-07-22 |
Ppl Therapeutics (Scotland) Limited |
Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals
|
GB8826446D0
(en)
*
|
1988-11-11 |
1988-12-14 |
Agricultural & Food Res |
Peptide production
|
EP0370813A3
(de)
*
|
1988-11-25 |
1991-06-19 |
Exemplar Corporation |
Rascher Überprüfungstest der Mutagenesis und Tetratogenesis
|
US5215904A
(en)
*
|
1989-01-27 |
1993-06-01 |
Wisconsin Alumni Research Foundation |
Method for producing a recombinant mammal in vivo
|
JPH02261386A
(ja)
*
|
1989-03-31 |
1990-10-24 |
Kyowa Hakko Kogyo Co Ltd |
組換えベクター
|
JPH04506751A
(ja)
*
|
1989-09-11 |
1992-11-26 |
ティー エスアイ コーポレーション |
遺伝子導入動物の乳汁中での成長ホルモンの生産
|
DE69033911D1
(de)
*
|
1989-10-24 |
2002-03-14 |
Chiron Corp |
System zur freisetzung von infektiösen proteinen
|
CA2351200A1
(en)
*
|
1989-12-01 |
1991-06-13 |
Gene Pharming Europe Bv |
Production of recombinant polypeptides by bovine species and transgenic methods
|
US5633076A
(en)
*
|
1989-12-01 |
1997-05-27 |
Pharming Bv |
Method of producing a transgenic bovine or transgenic bovine embryo
|
WO1991013151A1
(en)
*
|
1990-02-22 |
1991-09-05 |
Biogen, Inc. |
Improved expression of polypeptides
|
US5674898A
(en)
*
|
1990-03-05 |
1997-10-07 |
Genzyme Corporation |
Methods and therapeutic compositions for treating cystic fibrosis
|
JPH04365487A
(ja)
*
|
1990-04-11 |
1992-12-17 |
Consortium Elektrochem Ind Gmbh |
組換dna−構造体、組換ベクター、トランスゲン動物の乳からの蛋白質の取得法、トランスゲン動物の製法及びトランスゲン動物の乳
|
WO1992006104A1
(en)
*
|
1990-09-28 |
1992-04-16 |
The Dana-Farber Cancer Institute |
Adipocyte-specific dna sequences and use for the production of transgenic animals exhibiting altered fat metabolism
|
US5831141A
(en)
*
|
1991-01-11 |
1998-11-03 |
United States Of America As Represented By The Department Of Health And Human Services |
Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter
|
EP0591219B1
(de)
*
|
1991-01-11 |
2001-12-19 |
American Red Cross |
Expression von aktivem menschlichem Protein C im Milchdrüsengewebe transgener Tiere
|
US6984772B1
(en)
*
|
1994-02-18 |
2006-01-10 |
Virginia Tech Intellectual Properties, Inc. |
Transgenic non-human mammals producing fibrinogen in their milk
|
US6262336B1
(en)
|
1991-01-11 |
2001-07-17 |
American Red Cross |
Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoter
|
US5965789A
(en)
*
|
1991-01-11 |
1999-10-12 |
American Red Cross |
Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals
|
US5965788A
(en)
*
|
1992-06-12 |
1999-10-12 |
Institut National De La Recherche Agronomique |
Transgenic non-human mammal comprising a rabbit WAP promoter
|
US6268545B1
(en)
|
1991-06-12 |
2001-07-31 |
Institut National De La Recherche Agronomique |
Transgenic non-human mammal comprising a rabbit WAP promoter, uses thereof, and a DNA construct comprising the rabbit WAP promoter
|
AU669484B2
(en)
*
|
1991-07-31 |
1996-06-13 |
Peri Development Applications (1985) Ltd |
Transgenic protein production
|
GB9119338D0
(en)
*
|
1991-09-10 |
1991-10-23 |
Inst Of Animal Physiology And |
Control of gene expression
|
US6448469B1
(en)
|
1991-10-02 |
2002-09-10 |
Genzyme Corporation |
Production of membrane proteins in the milk of transgenic nonhuman mammals
|
US5298422A
(en)
*
|
1991-11-06 |
1994-03-29 |
Baylor College Of Medicine |
Myogenic vector systems
|
DK8892D0
(da)
|
1992-01-23 |
1992-01-23 |
Symbicom Ab |
Humant proteingen
|
US5616483A
(en)
*
|
1992-06-11 |
1997-04-01 |
Aktiebolaget Astra |
Genomic DNA sequences encoding human BSSL/CEL
|
AU4537393A
(en)
*
|
1992-06-15 |
1994-01-04 |
Gene Pharming Europe Bv |
Production of recombinant polypeptides by bovine species and transgenic methods
|
ES2146231T3
(es)
*
|
1992-07-08 |
2000-08-01 |
Innogenetics Nv |
Polipeptidos derivados de la endonexina 2 y que presentan una actividad de receptor del virus de la hepatitis b, y su utilizacion en composiciones diagnosticas y farmaceuticas.
|
DE4233152A1
(de)
|
1992-10-02 |
1994-04-07 |
Behringwerke Ag |
Antikörper-Enzym-Konjugate zur Prodrug-Aktivierung
|
US5667839A
(en)
*
|
1993-01-28 |
1997-09-16 |
Collagen Corporation |
Human recombinant collagen in the milk of transgenic animals
|
ES2146648T3
(es)
*
|
1993-03-09 |
2000-08-16 |
Genzyme Corp |
Procedimiento de aislamiento de proteinas de la leche.
|
DK75393D0
(da)
*
|
1993-06-24 |
1993-06-24 |
Symbicom Ab |
Production of protein
|
EP0710283A4
(de)
*
|
1993-07-22 |
1997-07-02 |
Merck & Co Inc |
DIE EXPRESSION VON MENSCHLICHEM INTERLEUKIN-1-g(b) IN EINEM TRANSGENEM TIER
|
CA2167581A1
(en)
*
|
1993-07-22 |
1995-02-02 |
Howard Y. Chen |
Transgenic animal model for cognitive disorders
|
US5856178A
(en)
*
|
1993-08-30 |
1999-01-05 |
Utah State University |
DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same
|
RU2025487C1
(ru)
*
|
1993-10-18 |
1994-12-30 |
Товарищество с ограниченной ответственностью "БиоПрогресс" |
Способ направленной генетической трансформации молочной железы животного и устройство для введения генетического материала в молочный проток молочной железы животного
|
US5750367A
(en)
*
|
1993-11-08 |
1998-05-12 |
Baylor College Of Medicine |
Human and mouse very low density lipoprotein receptors and methods for use of such receptors
|
US5827690A
(en)
*
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
AU5657800A
(en)
*
|
1993-12-20 |
2000-11-23 |
Gtc Biotherapeutics, Inc. |
Transgenic production of antibodies in milk
|
US5639940A
(en)
*
|
1994-03-03 |
1997-06-17 |
Pharmaceutical Proteins Ltd. |
Production of fibrinogen in transgenic animals
|
US5888814A
(en)
*
|
1994-06-06 |
1999-03-30 |
Chiron Corporation |
Recombinant host cells encoding TNF proteins
|
US6713662B1
(en)
*
|
1994-07-27 |
2004-03-30 |
Pharming Intellectual Property B.V. |
Production of collagen in the milk of transgenic mammals
|
US5959171A
(en)
*
|
1994-08-17 |
1999-09-28 |
Pharming B.V. |
Method for the production of biologically active polypeptides in a mammal's
|
US6518482B2
(en)
|
1994-09-13 |
2003-02-11 |
American National Red Cross |
Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor
|
US5880327A
(en)
|
1994-09-21 |
1999-03-09 |
American National Red Cross |
Transgenic mammals expressing human coagulation factor VIII
|
JPH10507637A
(ja)
*
|
1994-10-20 |
1998-07-28 |
メルク エンド カンパニー インコーポレーテッド |
インターロイキン−1β欠損トランスジェニック動物
|
US5780009A
(en)
*
|
1995-01-20 |
1998-07-14 |
Nexia Biotechnologies, Inc. |
Direct gene transfer into the ruminant mammary gland
|
US5843705A
(en)
*
|
1995-02-21 |
1998-12-01 |
Genzyme Transgenic Corporation |
Transgenically produced antithrombin III
|
ATE214101T1
(de)
*
|
1995-09-06 |
2002-03-15 |
Austrian Nordic Biotherapeutic |
Expression von heterologen genen in menschlichen brustzellen, einschliesslich menschliche brustkarzionomzellen unter der kontrolle von regulatorischen sequenzen von wap oder mmtv
|
US5907080A
(en)
*
|
1995-11-30 |
1999-05-25 |
Nexia Biotechnologies, Inc. |
Method for development of transgenic dwarf goats
|
US6613544B1
(en)
*
|
1995-12-22 |
2003-09-02 |
Amgen Inc. |
Osteoprotegerin
|
US7632922B1
(en)
*
|
1995-12-22 |
2009-12-15 |
Amgen, Inc. |
Osteoprotegerin
|
SE9601091L
(sv)
*
|
1996-03-21 |
1997-09-22 |
Joyce Carlson |
Användning av en proteinsubstans för bindning av steroid-liknande molekyler
|
US20020160970A1
(en)
*
|
1996-04-10 |
2002-10-31 |
Gyula Hadlaczky |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US6025155A
(en)
*
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US6077697A
(en)
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US20030033617A1
(en)
*
|
1996-04-10 |
2003-02-13 |
Gyula Hadlaczky |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
JP2001505405A
(ja)
*
|
1996-07-24 |
2001-04-24 |
ユニバーシティ・オブ・メリーランド |
ブチロフィリン遺伝子プロモータおよびその利用
|
US6478969B2
(en)
|
1996-09-06 |
2002-11-12 |
Pall Corporation |
Shear separation method and system
|
AU735463B2
(en)
*
|
1997-02-14 |
2001-07-12 |
American Red Cross |
Expression of active human factor IX in mammary tissue of transgenic animals
|
EP1793000A1
(de)
*
|
1997-02-25 |
2007-06-06 |
GTC Biotherapeutics, Inc. |
Transgen produzierte nicht-sekretierte Proteine
|
US6528699B1
(en)
|
1997-02-25 |
2003-03-04 |
Genzyme Transgenics Corporation |
Transgenically produced non-secreted proteins
|
DE69842225D1
(de)
|
1997-04-16 |
2011-05-26 |
Millennium Pharm Inc |
Zusammensetzung, umfassend einen Antikörper, der selektiv an ein cysteinreiches sekretiertes Protein (CRSP) bindet
|
US6210736B1
(en)
|
1997-06-17 |
2001-04-03 |
Genzyme Transgenics Corporation |
Transgenically produced prolactin
|
US6087166A
(en)
|
1997-07-03 |
2000-07-11 |
Basf Aktiengesellschaft |
Transcriptional activators with graded transactivation potential
|
US6323008B1
(en)
*
|
1997-08-14 |
2001-11-27 |
Neose Technologies, Inc. |
Methods for producing sialyloligosaccharides in a dairy source
|
WO1999009816A1
(de)
*
|
1997-08-22 |
1999-03-04 |
Roche Diagnostics Gmbh |
Verfahren zur gewinnung von insulin precursorproteinen
|
CA2306796A1
(en)
*
|
1997-10-20 |
1999-04-29 |
Genzyme Transgenics Corporation |
Novel modified msp-1 nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
|
US7157615B2
(en)
|
1998-03-17 |
2007-01-02 |
Nexia Biotechnologies, Inc. |
Production of biofilaments in transgenic animals
|
US6733991B1
(en)
*
|
1998-05-08 |
2004-05-11 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses therefor
|
CN1107445C
(zh)
*
|
1998-05-08 |
2003-05-07 |
上海市儿童医院上海医学遗传研究所 |
一种转基因羊的制备方法
|
US6746852B1
(en)
|
1998-05-08 |
2004-06-08 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses thereof
|
US7700353B2
(en)
*
|
1998-07-22 |
2010-04-20 |
E-P Therapeutics, Inc. |
Compositions and methods for inducing apoptosis in tumor cells
|
US20030027998A1
(en)
*
|
1998-10-30 |
2003-02-06 |
Holtzman Douglas A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
US20060205034A1
(en)
*
|
1998-10-30 |
2006-09-14 |
Millennium Pharmaceuticals, Inc. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
CA2354638C
(en)
|
1999-01-06 |
2013-03-19 |
Atlantic Biopharmaceuticals, Inc. |
Expression of secreted human alpha-fetoprotein in transgenic animals
|
US7208576B2
(en)
*
|
1999-01-06 |
2007-04-24 |
Merrimack Pharmaceuticals, Inc. |
Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
|
WO2000050057A1
(en)
*
|
1999-02-22 |
2000-08-31 |
Bernstein Eric F |
Compositions and methods for prevention of photoaging
|
EP2301947A3
(de)
|
1999-02-26 |
2011-11-23 |
Millennium Pharmaceuticals, Inc. |
Sekretierte Proteine und Verwendungen dafür
|
AR022952A1
(es)
|
1999-03-19 |
2002-09-04 |
Smithkline Beecham Corp |
ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
|
AU781915B2
(en)
*
|
1999-04-14 |
2005-06-23 |
Gtc Biotherapeutics, Inc. |
Method of purifying heterologous proteins
|
US6974684B2
(en)
*
|
2001-08-08 |
2005-12-13 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040023874A1
(en)
*
|
2002-03-15 |
2004-02-05 |
Burgess Catherine E. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040229779A1
(en)
*
|
1999-05-14 |
2004-11-18 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6774120B1
(en)
*
|
1999-06-01 |
2004-08-10 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
US20040067490A1
(en)
*
|
2001-09-07 |
2004-04-08 |
Mei Zhong |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6183803B1
(en)
|
1999-06-11 |
2001-02-06 |
Biosante Pharmaceuticals, Inc. |
Method for processing milk
|
KR20070087088A
(ko)
|
1999-06-25 |
2007-08-27 |
바스프 악티엔게젤샤프트 |
탄소 대사 및 에너지 생산과 관련된 단백질을 코딩하는코리네박테리움 글루타미쿰 유전자
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
EP2272953B1
(de)
|
1999-07-01 |
2014-09-24 |
Paik Kwang Industrial Co., Ltd. |
Gen aus Corynebacterium glutamicum kodierend für Phosphoenolpyruvat-Protein-Phosphotransferase
|
DE1246922T1
(de)
|
1999-07-01 |
2003-03-20 |
Basf Ag |
Für proteine des phosphoenolpyruvat:zucker phosphotransferase systems kodierende gene aus corynebacterium glutamicum
|
WO2001006989A2
(en)
*
|
1999-07-27 |
2001-02-01 |
Abgenix, Inc. |
Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
|
AU6913600A
(en)
*
|
1999-08-19 |
2001-03-13 |
Us Transgenics, Inc. |
Transgenic prothrombin and related thrombin precursors and transgenics, methods,compositions, uses and the like relating thereto
|
US6808710B1
(en)
|
1999-08-23 |
2004-10-26 |
Genetics Institute, Inc. |
Downmodulating an immune response with multivalent antibodies to PD-1
|
AT411997B
(de)
|
1999-09-14 |
2004-08-26 |
Baxter Ag |
Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
|
US6855806B1
(en)
*
|
1999-10-15 |
2005-02-15 |
Curagen Corporation |
Thymosin beta 10-like proteins and nucleic acids encoding same
|
AU784660B2
(en)
*
|
1999-10-19 |
2006-05-18 |
Curagen Corporation |
Genes associated with obesity and methods for using the same
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
AU1777301A
(en)
*
|
1999-11-19 |
2001-05-30 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US20030157592A1
(en)
*
|
1999-12-16 |
2003-08-21 |
Jens Lerchl |
Moss genes from physcomitrella patens encoding proteins involved in the synthesis of tocopherols and carotenoids
|
EP1254169B1
(de)
|
1999-12-30 |
2007-05-09 |
President And Fellows of Harvard College |
Verfahren zur modulierung der aktivität von th2-zellen durch modulierung der aktivität von xbp-1
|
AU2001239244B2
(en)
*
|
2000-02-09 |
2006-06-08 |
Basf Aktiengesellschaft |
Novel elongase gene and method for producing multiple-unsaturated fatty acids
|
WO2001064882A2
(en)
|
2000-02-29 |
2001-09-07 |
Millennium Pharmaceuticals, Inc. |
1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
|
EP1261712B1
(de)
*
|
2000-03-03 |
2006-12-13 |
Curagen Corporation |
Fctrx genannte proteine und dafür kodierende nuklein säure
|
CN101708165A
(zh)
*
|
2000-03-24 |
2010-05-19 |
生物领域医疗公司 |
用于主动栓塞术的微球体
|
US20030212022A1
(en)
*
|
2001-03-23 |
2003-11-13 |
Jean-Marie Vogel |
Compositions and methods for gene therapy
|
DE10016877A1
(de)
*
|
2000-04-05 |
2001-10-18 |
Scintec Diagnostics Gmbh Zug |
(Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung
|
EP1294912B1
(de)
|
2000-04-07 |
2007-02-21 |
BASF Plant Science GmbH |
Stress-gekoppeltes gtp-bindende protein und dessen verwendung in pflanzen
|
US20040005554A1
(en)
*
|
2000-05-08 |
2004-01-08 |
Tayar Nabil El |
Novel glycoproteins and methods of use thereof
|
US20030219786A1
(en)
*
|
2000-08-11 |
2003-11-27 |
Applied Research Systems Ars Holding N.V. |
Novel glycoproteins and methods of use thereof
|
EP1714661A3
(de)
|
2000-05-19 |
2012-03-14 |
The Center for Blood Research, INC. |
Verfahren zur Diagnose und Behandlung von hämostatischen Störungen durch Modulation der P-Selectin Aktivität
|
US20050048614A1
(en)
*
|
2000-06-13 |
2005-03-03 |
Children's Medical Center Corporation |
Biosynthetic oncolytic molecules and uses therefor
|
US20040034193A1
(en)
*
|
2001-06-13 |
2004-02-19 |
Samy Ashkar |
Biosynthetic oncolytic molecules and uses therefor
|
WO2002000730A2
(en)
|
2000-06-28 |
2002-01-03 |
Genetics Institute, Llc. |
Pd-l2 molecules: novel pd-1 ligands and uses therefor
|
WO2002006330A2
(en)
|
2000-07-18 |
2002-01-24 |
Millennium Pharmaceuticals, Inc. |
13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
|
US6924412B1
(en)
*
|
2000-07-21 |
2005-08-02 |
Arriwan Holding B.V. |
Means and methods for raising antibody concentration in compartments of the body of a non-human animal
|
US20040023259A1
(en)
*
|
2000-07-26 |
2004-02-05 |
Luca Rastelli |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US6677500B2
(en)
*
|
2000-08-15 |
2004-01-13 |
Board Of Trustees Of The University Of Illinois |
Ungulates expressing exogenous IGF-I in their milk
|
JP5113314B2
(ja)
|
2000-09-01 |
2013-01-09 |
ザ センター フォー ブラッド リサーチ インク |
所望のコンホメーションで安定させた改変ポリペプチド及び該ポリペプチドの作製方法
|
HUP0301246A3
(en)
|
2000-09-13 |
2005-12-28 |
Novo Nordisk Healthcare Ag |
Human coagulation factor vii variants
|
US20030176344A1
(en)
*
|
2000-09-14 |
2003-09-18 |
Decode Genetics Ehf. |
Human osteoporosis gene
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
EP1911837B1
(de)
*
|
2000-09-28 |
2011-05-25 |
Bioriginal Food & Science Corp. |
FAD5-2, Mitglied der Desaturase-Familie und Verwendungen davon
|
DE60140903D1
(de)
|
2000-10-18 |
2010-02-04 |
Brigham & Womens Hospital |
E-selectin/l-selectin-liganden-polypeptide hämatopoetischer zellen und verfahren zu deren verwendung
|
NZ526708A
(en)
|
2000-11-28 |
2005-07-29 |
Wyeth Corp |
Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
BR0115728A
(pt)
|
2000-11-28 |
2003-09-23 |
Wyeth Corp |
Análise da expressão de ácidos nucléicos kiaa e polipeptìdeos úteis no diagnóstico e tratamento de cáncer de próstata
|
JP2005516579A
(ja)
|
2000-12-08 |
2005-06-09 |
キュラジェン コーポレイション |
障害に関連する結節硬化複合症の検出法および処置法
|
US7247704B2
(en)
|
2000-12-18 |
2007-07-24 |
Arriva Pharmaceuticals, Inc. |
Multifunctional protease inhibitors and their use in treatment of disease
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
US20020142397A1
(en)
*
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
EP1356035B1
(de)
|
2000-12-22 |
2011-03-16 |
Kyowa Hakko Kirin Co., Ltd. |
Verfahren zur klonierung von nichtmenschliche säugern unter verwendung von reprogrammiertem donorchromatin oder donorzellen
|
ES2390425T3
(es)
|
2000-12-22 |
2012-11-12 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Uso de moléculas de orientación repulsivas (RGM) y sus moduladores
|
US6964849B2
(en)
|
2001-01-11 |
2005-11-15 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
US20040043928A1
(en)
*
|
2001-08-02 |
2004-03-04 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
GB0103174D0
(en)
*
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Plc |
Novel method of treatment
|
US20040133930A1
(en)
*
|
2002-03-11 |
2004-07-08 |
Cooper Julian D. |
Production of high levels of transgenic factor ix without gene rescue, and its therapeutic uses
|
US20090081199A1
(en)
*
|
2001-03-20 |
2009-03-26 |
Bioxell S.P.A. |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8231878B2
(en)
*
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
CA2342376C
(en)
*
|
2001-03-20 |
2013-11-12 |
Marco Colonna |
A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
WO2002076196A1
(en)
|
2001-03-22 |
2002-10-03 |
Abbott Gmbh & Co. Kg |
Transgenic animals expressing antibodies specific for genes of interest and uses thereof
|
EP1373493B1
(de)
|
2001-03-22 |
2013-07-31 |
Novo Nordisk Health Care AG |
Derivat des koagulationsfaktors vii
|
GB0107510D0
(en)
*
|
2001-03-26 |
2001-05-16 |
Univ Bristol |
New elongase gene and a process for the production of -9-polyunsaturated fatty acids
|
WO2002079499A1
(en)
|
2001-04-02 |
2002-10-10 |
Wyeth |
Pd-1, a receptor for b7-4, and uses therefor
|
MXPA03009415A
(es)
|
2001-04-16 |
2004-01-29 |
Wyeth Corp |
ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
|
US20070015144A9
(en)
*
|
2001-05-25 |
2007-01-18 |
Genset, S.A. |
Human cDNAs and proteins and uses thereof
|
JP2005508141A
(ja)
*
|
2001-05-25 |
2005-03-31 |
セローノ ジェネティクス インスティテュート ソシエテ アニニム |
ヒトcDNAおよびタンパク質、ならびにそれらの使用
|
JP2004537297A
(ja)
*
|
2001-06-07 |
2004-12-16 |
ワイス |
G−タンパク質結合レセプターおよびその使用
|
US20040029790A1
(en)
*
|
2001-07-05 |
2004-02-12 |
Meera Patturajan |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
US20030129613A1
(en)
*
|
2001-07-05 |
2003-07-10 |
Fernandes Elma R. |
Novel human proteins and polynucleotides encoding them
|
US20030087274A1
(en)
*
|
2001-07-05 |
2003-05-08 |
Anderson David W. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040030096A1
(en)
*
|
2001-08-02 |
2004-02-12 |
Linda Gorman |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
US7220718B2
(en)
*
|
2001-08-03 |
2007-05-22 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Oral treatment of hemophilia
|
CA2456571A1
(en)
|
2001-08-10 |
2003-02-20 |
Genset Sa |
Human secreted proteins, their encoding polynucleotides, and uses thereof
|
CA2459961A1
(en)
|
2001-09-05 |
2003-03-13 |
Basf Plant Science Gmbh |
Protein phosphatase stress-related polypeptides and methods of use in plants
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
US20070082337A1
(en)
*
|
2004-01-27 |
2007-04-12 |
Compugen Ltd. |
Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
|
AU2002336760A1
(en)
*
|
2001-09-26 |
2003-06-10 |
Mayo Foundation For Medical Education And Research |
Mutable vaccines
|
ATE532858T1
(de)
|
2001-09-27 |
2011-11-15 |
Novo Nordisk Healthcare Ag |
Menschliche gerinnungsfaktor-vii-polypeptide
|
US20030199442A1
(en)
*
|
2001-10-09 |
2003-10-23 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6902921B2
(en)
*
|
2001-10-30 |
2005-06-07 |
454 Corporation |
Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
|
US20050124022A1
(en)
*
|
2001-10-30 |
2005-06-09 |
Maithreyan Srinivasan |
Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
|
US6956114B2
(en)
|
2001-10-30 |
2005-10-18 |
'454 Corporation |
Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
|
DE10154180A1
(de)
|
2001-11-05 |
2003-05-15 |
Basf Ag |
gene die für genetische Stabilitäts-, genexpressions-und Faltungsproteine codieren
|
DE10154270A1
(de)
|
2001-11-05 |
2003-05-15 |
Basf Ag |
Gene die für Kohlenstoffmetabolismus- und Energieproduktion-Proteine codieren
|
WO2003042362A2
(en)
|
2001-11-09 |
2003-05-22 |
Dana-Farber Cancer Institute, Inc. |
PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
|
EP1451325B1
(de)
|
2001-11-09 |
2011-05-18 |
BASF Plant Science GmbH |
Mit stress assoziierte transkriptionsfaktor-spezifische polypeptide und verfahren zur verwendung in pflanzen
|
DE10155505A1
(de)
|
2001-11-13 |
2003-05-22 |
Basf Ag |
Gene die für Glucose-6-Phosphat-Dehydrogenase Proteine codieren
|
CN100374457C
(zh)
|
2001-11-14 |
2008-03-12 |
森托科尔公司 |
抗il-6抗体、组合物、方法和用途
|
WO2003052120A2
(en)
*
|
2001-12-14 |
2003-06-26 |
President And Fellows Of Harvard College |
Dual inhibition of sister chromatide separation at metaphase
|
US20030170691A1
(en)
*
|
2001-12-19 |
2003-09-11 |
Millennium Pharmaceuticals, Inc. |
Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
|
US20060253913A1
(en)
*
|
2001-12-21 |
2006-11-09 |
Yue-Jin Huang |
Production of hSA-linked butyrylcholinesterases in transgenic mammals
|
EP1458860A2
(de)
*
|
2001-12-21 |
2004-09-22 |
Nexia Biotechnologies, Inc. |
Herstellung von butyrylcholinesterase durch transgene säugetiere
|
US20070016969A1
(en)
*
|
2002-01-18 |
2007-01-18 |
Animal Technology Institute Taiwan |
Expression vector for hirudin and transformed cells and transgenic animals containing said vector
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
DE60314495T2
(de)
|
2002-02-07 |
2008-03-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Aminosäuresequenzen, die in der lage sind die durchdringung einer biologischen barriere zu erleichtern
|
US20050215478A1
(en)
*
|
2002-02-07 |
2005-09-29 |
Ben-Sasson Shmuel A |
Amino acid sequences capable of facilitating penetration across a biological barrier
|
US20040117862A1
(en)
*
|
2002-03-11 |
2004-06-17 |
Cooper Julian D. |
Production of high levels of transgenic factor VII with engineered stability and its therapeutic uses
|
SI1997512T1
(sl)
|
2002-04-09 |
2014-03-31 |
Biogen Idec Ma Inc. |
Postopki za zdravljenje stanj, povezanih s TWEAK-om
|
EP2392659B1
(de)
|
2002-06-17 |
2015-01-14 |
Thrasos Innovation, Inc. |
TDF-zugehörige Einzeldomänenverbindungen und Analoge davon
|
EP1545608A4
(de)
|
2002-06-28 |
2006-09-13 |
Centocor Inc |
Ch1-deletierte säugetier-mimetikörper, zusammensetzungen, verfahren und anwendungen
|
WO2004003511A2
(en)
*
|
2002-07-01 |
2004-01-08 |
Wayne State University |
Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
|
US7250551B2
(en)
*
|
2002-07-24 |
2007-07-31 |
President And Fellows Of Harvard College |
Transgenic mice expressing inducible human p25
|
TWI323265B
(en)
|
2002-08-06 |
2010-04-11 |
Glaxo Group Ltd |
Antibodies
|
DE10238433A1
(de)
*
|
2002-08-16 |
2004-03-04 |
Justus-Liebig-Universität Giessen |
Verfahren zur Bestimmung des allelischen Zustandes des 5'-Ende des alpha-S1-Kaseingenes
|
CA2496272A1
(en)
|
2002-08-20 |
2004-03-04 |
Millennium Pharmaceuticals, Inc. |
Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
|
NZ539459A
(en)
*
|
2002-11-08 |
2009-02-28 |
Kirin Pharma Kk |
Transgenic ungulates having reduced prion protein activity and uses thereof
|
US20060009378A1
(en)
*
|
2002-11-14 |
2006-01-12 |
Itshak Golan |
Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
WO2004056868A2
(en)
*
|
2002-12-19 |
2004-07-08 |
Endocube Sas |
Nf-hev compositions and methods of use
|
WO2004060791A1
(en)
|
2003-01-07 |
2004-07-22 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
EP1599168A2
(de)
*
|
2003-03-04 |
2005-11-30 |
Janssen Pharmaceutica N.V. |
Relaxin3-gpcr135-komplexe und ihre herstellung und verwendung
|
WO2004078061A2
(en)
|
2003-03-04 |
2004-09-16 |
Aspenbio, Inc. |
Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone
|
WO2004078991A2
(en)
|
2003-03-04 |
2004-09-16 |
Yeda Research And Development Co. Ltd. |
Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
|
CN101818138A
(zh)
|
2003-03-18 |
2010-09-01 |
诺和诺德医疗保健公司 |
生产含有gla残基的丝氨酸蛋白酶的方法
|
GB0306309D0
(en)
*
|
2003-03-19 |
2003-04-23 |
Glaxo Group Ltd |
Method of treatment
|
US7524938B2
(en)
|
2003-04-04 |
2009-04-28 |
Yeda Research And Development Co., Ltd. |
Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
|
AU2004227204B2
(en)
|
2003-04-08 |
2010-06-03 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
JP5137400B2
(ja)
*
|
2003-06-30 |
2013-02-06 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. |
アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法
|
EP1648931B1
(de)
|
2003-07-21 |
2011-02-09 |
Transgene S.A. |
Multifunktionelle cytokine
|
WO2005014616A2
(en)
*
|
2003-08-07 |
2005-02-17 |
Janssen Pharmaceutica N.V. |
Complexes of gpcr142 and relaxin3 or insl5, and their production and use
|
WO2005019434A2
(en)
|
2003-08-26 |
2005-03-03 |
The Regents Of The University Of Colorado, A Body Corporate |
Serine protease inhibitors for treatment of bacterial infections
|
JP2007503838A
(ja)
*
|
2003-09-05 |
2007-03-01 |
ジーティーシー バイオセラピューティクス, インコーポレイティド |
トランスジェニック動物の乳汁中での融合タンパク質の産生方法
|
US20060258576A1
(en)
*
|
2003-09-05 |
2006-11-16 |
Licentia, Ltd |
Gdnf-related neuropeptides
|
CN101870729A
(zh)
|
2003-09-09 |
2010-10-27 |
诺和诺德医疗保健公司 |
凝固因子ⅶ多肽
|
US7297336B2
(en)
|
2003-09-12 |
2007-11-20 |
Baxter International Inc. |
Factor IXa specific antibodies displaying factor VIIIa like activity
|
US20050136103A1
(en)
*
|
2003-09-17 |
2005-06-23 |
Ben-Sasson Shmuel A. |
Compositions capable of facilitating penetration across a biological barrier
|
WO2005030931A2
(en)
*
|
2003-09-23 |
2005-04-07 |
Favrille, Inc. |
Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
EP1670350A4
(de)
|
2003-10-07 |
2008-02-13 |
Millennium Pharm Inc |
Nukleinsäuremoleküle und proteine für die identifizierung, beurteilung, prävention und behandlung von ovarialkrebs
|
US7418396B2
(en)
*
|
2003-10-14 |
2008-08-26 |
Broadcom Corporation |
Reduced memory implementation technique of filterbank and block switching for real-time audio applications
|
IN2014DN02483A
(de)
|
2003-10-24 |
2015-05-15 |
Selexis Sa |
|
IL158868A0
(en)
*
|
2003-11-13 |
2004-05-12 |
Yeda Res & Dev |
Methods of generating and using stem cells enriched with immature primitive progenitor
|
US20050125914A1
(en)
*
|
2003-11-18 |
2005-06-16 |
Gerard Malle |
Hair shaping composition comprising at least one- non-hydroxide base
|
JP4412989B2
(ja)
*
|
2003-12-15 |
2010-02-10 |
株式会社日立製作所 |
複数の記憶システムを有するデータ処理システム
|
DE10359661A1
(de)
*
|
2003-12-18 |
2005-07-28 |
Basf Ag |
Genvarianten die für Proteine aus dem Stoffwechselweg von Feinchemikalien codieren
|
CA2487098A1
(en)
*
|
2003-12-22 |
2005-06-22 |
F. Hoffmann-La Roche Ag |
Novel targets for obesity from fat tissue
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US20060147946A1
(en)
*
|
2004-01-27 |
2006-07-06 |
Pinchas Akiva |
Novel calcium channel variants and methods of use thereof
|
US20050186608A1
(en)
*
|
2004-02-19 |
2005-08-25 |
Olsen Byron V. |
Method for the production of transgenic proteins useful in the treatment of obesity and diabetes
|
US20050197496A1
(en)
*
|
2004-03-04 |
2005-09-08 |
Gtc Biotherapeutics, Inc. |
Methods of protein fractionation using high performance tangential flow filtration
|
WO2005097175A2
(en)
*
|
2004-03-31 |
2005-10-20 |
Centocor, Inc. |
Human glp-1 mimetibodies, compositions, methods and uses
|
NZ550106A
(en)
|
2004-04-22 |
2009-06-26 |
Kyowa Hakko Kirin Co Ltd |
Transgenic animals and uses thereof
|
US20050245444A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Yann Echelard |
Method of using recombinant human antithrombin for neurocognitive disorders
|
KR100646222B1
(ko)
|
2004-06-03 |
2006-11-23 |
대한민국 |
돼지 유선특이 발현벡터 및 이를 이용한 형질전환 동물 유선에서 유전자 발현방법
|
CA2571218C
(en)
|
2004-06-17 |
2015-11-03 |
William D. Carlson |
Tdf-related compounds and analogs thereof
|
US7288385B2
(en)
*
|
2004-06-25 |
2007-10-30 |
The Salk Institute For Biological Studies |
Increasing life span by modulation of Smek
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
WO2006013552A2
(en)
|
2004-08-02 |
2006-02-09 |
Ramot At Tel Aviv University Ltd. |
Articles of peptide nanostructures and method of forming the same
|
WO2006017621A2
(en)
*
|
2004-08-02 |
2006-02-16 |
Janssen Pharmaceutica N.V. |
IRAK1c SPLICE VARIANT AND ITS USE
|
US7893197B2
(en)
*
|
2004-08-25 |
2011-02-22 |
Janssen Pharmaceutica N.V. |
Relaxin-3 chimeric polypeptides and their preparation and use
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
US7786086B2
(en)
|
2004-09-08 |
2010-08-31 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
US20060063187A1
(en)
*
|
2004-09-15 |
2006-03-23 |
Hotamisligil Gokhan S |
Modulation of XBP-1 activity for treatment of metabolic disorders
|
WO2006044352A2
(en)
*
|
2004-10-12 |
2006-04-27 |
Janssen Pharmaceutica N.V. |
Canine cholecystokinin 1 receptor materials and their use
|
JP4271122B2
(ja)
*
|
2004-10-15 |
2009-06-03 |
財団法人 ひろしま産業振興機構 |
カイコでの組換えタンパク質製造のためのポリヌクレオチド
|
EP2298341A3
(de)
|
2004-10-21 |
2011-07-13 |
Wyeth LLC |
Immunogene zusammensetzungen von staphylococcus epidermidis polypeptide und polynucleotide antigenen
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
US20060121004A1
(en)
*
|
2004-12-07 |
2006-06-08 |
Yann Echelard |
Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
|
US20060130159A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Nick Masiello |
Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
|
CN1274829C
(zh)
|
2004-12-10 |
2006-09-13 |
四川大学华西医院 |
抗eb病毒所致肿瘤多肽及其应用与制备方法
|
US20060154285A1
(en)
*
|
2004-12-29 |
2006-07-13 |
Robishaw Janet D |
Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2)
|
EP1844403A4
(de)
*
|
2005-01-16 |
2010-06-23 |
Zlango Ltd |
Bildzeichenkommunikation
|
US20080082678A1
(en)
*
|
2005-01-16 |
2008-04-03 |
Zlango Ltd. |
Communications Network System and Methods for Using Same
|
WO2007080558A2
(en)
*
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Communications network system and methods for using same
|
US20080019905A9
(en)
*
|
2005-02-18 |
2008-01-24 |
Strome Scott E |
Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
US8226926B2
(en)
|
2005-05-09 |
2012-07-24 |
Biosphere Medical, S.A. |
Compositions and methods using microspheres and non-ionic contrast agents
|
WO2006122224A1
(en)
|
2005-05-11 |
2006-11-16 |
Wayne State University |
Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in pseudomonas aeruginosa
|
AU2006243923B2
(en)
|
2005-05-11 |
2011-09-22 |
Wayne State University |
Novel targets for the identification of antibiotics that are not susceptible to antibiotic resistance
|
PL1899364T3
(pl)
|
2005-05-17 |
2020-08-24 |
University Of Connecticut |
Kompozycje i sposoby immunomodulacji w organizmie
|
BRPI0611879A2
(pt)
|
2005-06-17 |
2012-08-28 |
Basf Plant Science Gmbh |
usos de um ácido nucleico, e de um primeiro ácido nucleico isolado que hibridiza sob condições estringentes para um segundo ácido nucleico, métodos para aumentar a toleráncia de uma planta transgênica contendo o ácido nucleico que codifica o polipeptìdeo relacionado com estresse do tipo lectina de uma proteìna quinase, célula de planta transgênica, planta transgênica, semente, polipeptìdeo, e, seqüência de ácido nucleico
|
CA2612479A1
(en)
*
|
2005-06-29 |
2007-05-10 |
Cameron Malcolm Lang Clokie |
Production of bone morphogenic proteins (bmps) in transgenic mammals
|
JP2009501006A
(ja)
|
2005-06-30 |
2009-01-15 |
セントカー・インコーポレーテツド |
抗il−23抗体、組成物、方法および用途
|
WO2007007317A1
(en)
|
2005-07-07 |
2007-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid agents for downregulating h19, and methods of using same
|
EP3138403A1
(de)
|
2005-08-09 |
2017-03-08 |
Revivicor, Inc. |
Ctla4-ig exprimierende transgene huftiere und verwendungen davon
|
EP1926817A2
(de)
|
2005-09-14 |
2008-06-04 |
Novo Nordisk Health Care AG |
Menschliche gerinnungsfaktor-vii-polypeptide
|
CA2623415A1
(en)
|
2005-09-20 |
2007-03-29 |
Thrasos, Inc. |
Tdf-related compounds and analogs thereof
|
US8795674B2
(en)
|
2005-09-30 |
2014-08-05 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Methods and compositions for modulating immune tolerance
|
US8906864B2
(en)
|
2005-09-30 |
2014-12-09 |
AbbVie Deutschland GmbH & Co. KG |
Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
|
IL172297A
(en)
|
2005-10-03 |
2016-03-31 |
Compugen Ltd |
Soluble vegfr-1 variants for the diagnosis of preeclampsia
|
US10004828B2
(en)
*
|
2005-10-11 |
2018-06-26 |
Romat at Tel-Aviv University Ltd. |
Self-assembled Fmoc-ff hydrogels
|
CA2626262C
(en)
|
2005-10-18 |
2015-09-08 |
Homme W. Hellinga |
Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity
|
KR20080068089A
(ko)
*
|
2005-10-21 |
2008-07-22 |
지티씨바이오쎄라퓨틱스,인크. |
항체 의존성 세포 독성 활성이 증강된 항체, 그 생산 및사용 방법
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
WO2007078615A2
(en)
*
|
2005-12-15 |
2007-07-12 |
Cavit Sciences, Inc |
Methods and compositions for treatment of cancer
|
GB0525662D0
(en)
|
2005-12-16 |
2006-01-25 |
Glaxo Group Ltd |
Immunoglobulins
|
HUE034269T2
(en)
|
2005-12-29 |
2018-02-28 |
Janssen Biotech Inc |
Human anti-IL-23 antibodies, preparations, methods and applications
|
IL173104A0
(en)
|
2006-01-12 |
2006-06-11 |
Yeda Res & Dev |
Siva and ubiquintination
|
EP1977312A2
(de)
|
2006-01-16 |
2008-10-08 |
Zlango Ltd. |
Bildzeichenkommunikation
|
EP2216339A1
(de)
|
2006-01-16 |
2010-08-11 |
Compugen Ltd. |
Neuartiges Nukleotid und neuartige Aminosäuresequenzen und Verfahren zu deren Verwendung zur Diagnose
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US7553940B2
(en)
*
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting EPO polypeptides and derivatives thereof and methods thereof
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20090221072A1
(en)
*
|
2006-02-15 |
2009-09-03 |
Chen Thomas T |
Compositions and methods for modulating cell differentiation
|
US7531632B2
(en)
*
|
2006-02-16 |
2009-05-12 |
Gtc Biotherapeutics, Inc. |
Clarification of transgenic milk using depth filtration
|
US7807364B2
(en)
|
2006-03-03 |
2010-10-05 |
University Of Southern California |
Angiogenesis pathway gene polymorphisms for therapy selection
|
CA2648035A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Centocor, Inc. |
Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions or renal disease associated anemia
|
WO2007127151A2
(en)
*
|
2006-04-24 |
2007-11-08 |
The Cleveland Clinic Foundation |
Non-human model of autoimmune disease
|
CA2652346A1
(en)
|
2006-05-15 |
2007-11-22 |
Paratek Pharmaceuticals, Inc. |
Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
|
US8153369B2
(en)
|
2006-06-05 |
2012-04-10 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
US8124831B2
(en)
*
|
2006-07-06 |
2012-02-28 |
Duke University |
Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase
|
EP2471815B1
(de)
|
2006-07-11 |
2016-03-30 |
University Of Medicine And Dentistry Of New Jersey |
Proteine, Nukleinsäuren zu deren Kodierung und entsprechende Verwendungsverfahren
|
CA2659809A1
(en)
*
|
2006-08-04 |
2008-02-14 |
Pharmathene Inc. |
Long half-life recombinant butyrylcholinesterase
|
US9277737B2
(en)
|
2006-09-21 |
2016-03-08 |
Probiodrug Ag |
Mouse models carrying a knock-out mutation of the QPCTL-gene
|
KR101161923B1
(ko)
|
2006-10-03 |
2012-07-03 |
유니버시티 오브 메디신 앤드 덴티스트리 오브 뉴 저지 |
Atap 펩티드, 상기 펩티드를 엔코딩하는 핵산 및 이들과 관련된 사용 방법
|
US9018440B2
(en)
*
|
2006-10-27 |
2015-04-28 |
Stowers Institute For Medical Research |
Fluorescent mouse model
|
TW200843794A
(en)
*
|
2006-12-21 |
2008-11-16 |
Centocor Inc |
Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
|
US7928083B2
(en)
*
|
2007-01-16 |
2011-04-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
H19 silencing nucleic acid agents for treating rheumatoid arthritis
|
AU2008205457A1
(en)
*
|
2007-01-18 |
2008-07-24 |
University Of Southern California |
Gene polymorphisms predictive for dual TKI therapy
|
ZA200904353B
(en)
|
2007-01-19 |
2010-09-29 |
Probiodrug Ag |
In vivo screening models for treatment of alzheimer's disease and other Qpct-related disorders
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
US20110189663A1
(en)
|
2007-03-05 |
2011-08-04 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
WO2008116032A1
(en)
|
2007-03-21 |
2008-09-25 |
Effat Emamian |
Compositions and methods for inhibiting tumor cell growth
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2014064687A1
(en)
|
2012-10-22 |
2014-05-01 |
Deliversir Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
PL2144633T4
(pl)
*
|
2007-04-23 |
2015-02-27 |
Sabag Rfa Ltd |
Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
|
ES2614735T3
(es)
|
2007-07-23 |
2017-06-01 |
Janssen Biotech, Inc. |
Métodos y composiciones para tratar los trastornos relacionados con fibrosis usando antagonistas de la IL-17
|
US8415455B2
(en)
|
2007-09-04 |
2013-04-09 |
Compugen Ltd |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
WO2009034158A2
(en)
*
|
2007-09-12 |
2009-03-19 |
Probiodrug Ag |
Transgenic mice
|
EP2915564B1
(de)
|
2007-09-28 |
2020-11-04 |
Portola Pharmaceuticals, Inc. |
Gegenmittel für Faktor-XA-Hemmer und Verfahren zur Verwendung davon
|
WO2009055656A2
(en)
|
2007-10-26 |
2009-04-30 |
Centocor, Inc. |
Vectors, host cells, and methods of production and uses
|
ES2732735T3
(es)
|
2007-10-31 |
2019-11-25 |
Prec Biosciences Inc |
Meganucleasas monocatenarias diseñadas racionalmente con secuencias de reconocimiento no palindrómicas
|
TW200944231A
(en)
|
2007-11-30 |
2009-11-01 |
Glaxo Group Ltd |
Antigen-binding constructs
|
US8501449B2
(en)
|
2007-12-04 |
2013-08-06 |
Proteon Therapeutics, Inc. |
Recombinant elastase proteins and methods of manufacturing and use thereof
|
KR100912038B1
(ko)
|
2007-12-31 |
2009-08-12 |
전남대학교산학협력단 |
돼지 β-카제인 게놈 DNA, 및 이를 포함하는 재조합벡터 및 형질전환체
|
NZ586665A
(en)
*
|
2008-01-14 |
2011-12-22 |
Probiodrug Ag |
MOUSE MODELS CARRYING A KNOCK-OUT MUTATION OF THE GLUTAMINYL CYCLASE GENE (Qpct)
|
EP2245055A2
(de)
*
|
2008-01-31 |
2010-11-03 |
Compugen Ltd. |
Polypeptide und polynukleotide und deren verwendung als arzneimittel-target zur herstellung von arzneimitteln und biologika
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
EP2271772B1
(de)
|
2008-03-11 |
2014-07-16 |
Sequenom, Inc. |
Tests auf nukleinsäurebasis zur pränatalen geschlechtsbestimmung
|
US20110229460A1
(en)
*
|
2008-05-01 |
2011-09-22 |
Gtc Biotherapeutics, Inc. |
anti-cd137 antibody as an agent in the treatment of inflammatory conditions
|
MX2010014358A
(es)
|
2008-06-20 |
2011-07-04 |
Wyeth Llc |
Composiciones y metodos de uso del orf1358 de cepas estreptococicas beta-hemoliticas.
|
WO2010002160A2
(ko)
*
|
2008-06-30 |
2010-01-07 |
조아제약주식회사 |
돼지의 알파에스 1 카제인 유전자, 그 프로모터 및 그의 용도
|
WO2010002082A1
(en)
*
|
2008-06-30 |
2010-01-07 |
Cho-A Pharm Co., Ltd. |
A gene of porcine beta-casein, a promoter of the same and the use thereof
|
US8999661B2
(en)
*
|
2008-07-30 |
2015-04-07 |
Dana-Farber Cancer Institute, Inc. |
Compositions for detecting cell death and methods of use thereof
|
US8563697B2
(en)
|
2008-08-14 |
2013-10-22 |
Cephalon Australia Pty. Ltd. |
Anti-IL-12/IL-23 antibodies
|
WO2010029537A1
(en)
|
2008-09-10 |
2010-03-18 |
Ben Gurion University Of The Negev Research And Development Authority |
Antinecrotic activity of alpha 1-antitrypsin
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
ES2592216T3
(es)
|
2008-09-26 |
2016-11-28 |
Dana-Farber Cancer Institute, Inc. |
Anticuerpos anti-PD-1, PD-L1 y PD-L2 humanos y sus usos
|
SI2340038T1
(en)
|
2008-10-10 |
2018-05-31 |
Children's Medical Center Corporation |
A biochemically stabilized HIV-1 ENV TRIMER vaccine
|
WO2010061393A1
(en)
|
2008-11-30 |
2010-06-03 |
Compugen Ltd. |
He4 variant nucleotide and amino acid sequences, and methods of use thereof
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
EP2633854B1
(de)
|
2008-12-05 |
2015-09-16 |
Yeda Research And Development Co. Ltd. |
miRNA-9 or miRNA-9* zur Verwendung in der Behandlung von ALS
|
US9181315B2
(en)
|
2009-01-08 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
WO2010088522A2
(en)
|
2009-01-30 |
2010-08-05 |
Ab Biosciences, Inc. |
Novel lowered affinity antibodies and uses therefor
|
US8362203B2
(en)
*
|
2009-02-10 |
2013-01-29 |
Wayne State University |
Non-natural peptides as models for the development of antibiotics
|
CA2753263A1
(en)
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Multivalent and/or multispecific rankl-binding constructs
|
CA2753287A1
(en)
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Antigen-binding constructs
|
CA2753332A1
(en)
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Antigen-binding constructs
|
EP3121271B1
(de)
|
2009-03-30 |
2019-07-24 |
Portola Pharmaceuticals, Inc. |
Gegenmittel für faktor-xa-hemmer und verfahren zur verwendung davon
|
CA2757237A1
(en)
|
2009-04-01 |
2010-10-14 |
Jane Elizabeth Clarkson |
Anti-il-23 immunoglobulins
|
WO2010122090A1
(en)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
Fgfr1c antibody combinations
|
US9023767B2
(en)
*
|
2009-05-07 |
2015-05-05 |
Memorial Sloan-Kettering Cancer Center |
γ-Secretase substrates and methods of use
|
AU2010251176A1
(en)
*
|
2009-05-19 |
2011-12-08 |
Probiodrug Ag |
Mouse models carrying a knock-out mutation of the QPCTL-gene
|
US20100304873A1
(en)
*
|
2009-05-28 |
2010-12-02 |
Lipa Markowitz |
Bowling Ball and Football Game Controller
|
US8435961B2
(en)
*
|
2009-06-26 |
2013-05-07 |
Massachusetts Institute Of Technology |
Methods and compositions for increasing the activity of inhibitory RNA
|
US8268550B2
(en)
*
|
2009-06-26 |
2012-09-18 |
Massachusetts Institute Of Technology |
Compositions and methods for identification of PARP function, inhibitors, and activators
|
US20110097329A1
(en)
|
2009-06-26 |
2011-04-28 |
Massachusetts Institute Of Technology |
Compositions and methods for treating cancer and modulating stress granule formation
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011008885A1
(en)
|
2009-07-15 |
2011-01-20 |
Portola Pharmaceuticals, Inc. |
Unit dose formulation of antidotes for factor xa inhibitors and methods of using the same
|
EP2454281B1
(de)
|
2009-07-17 |
2018-11-14 |
Omeros Corporation |
Masp isoforme als inhibitoren c von komplementaktivation
|
CN106619515A
(zh)
|
2009-08-27 |
2017-05-10 |
工业研究与发展基金会有限公司 |
脂质体组合物及其用途
|
PL2496246T3
(pl)
|
2009-11-03 |
2018-09-28 |
Grifols Therapeutics Llc |
Kompozycja, sposób i zestaw dla inhibitora proteinazy alpha-1
|
EP2499159B1
(de)
|
2009-11-13 |
2017-01-04 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen, kits und verfahren zur diagnose, prognose, überwachung, behandlung und modulierung von auf transplantationen folgenden lymphoproliferativen erkrankungen und hypoxievermittelten angiogeneseerkrankungen mithilfe von galectin-1
|
NZ600271A
(en)
|
2009-11-24 |
2013-09-27 |
Grifols Therapeutics Inc |
Lyophilization methods, compositions, and kits
|
SG181563A1
(en)
|
2009-12-08 |
2012-07-30 |
Abbott Gmbh & Co Kg |
Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
|
WO2011084145A2
(en)
|
2009-12-21 |
2011-07-14 |
Pharmathene, Inc. |
Recombinant butyrylcholinesterases and truncates thereof
|
WO2011087760A2
(en)
|
2009-12-22 |
2011-07-21 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
US10429384B2
(en)
|
2010-01-22 |
2019-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
CN102822202B
(zh)
|
2010-01-27 |
2015-07-22 |
耶达研究及发展有限公司 |
抑制金属蛋白的抗体
|
WO2011094593A2
(en)
|
2010-01-28 |
2011-08-04 |
Ab Biosciences, Inc. |
Novel lowered affinity antibodies and methods of marking the same
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
CN102933231B
(zh)
|
2010-02-10 |
2015-07-29 |
伊缪诺金公司 |
Cd20抗体及其用途
|
WO2011104708A2
(en)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
US9815876B2
(en)
|
2010-03-05 |
2017-11-14 |
Omeros Corporation |
Chimeric inhibitor molecules of complement activation
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US9631018B2
(en)
|
2010-03-26 |
2017-04-25 |
The Trustees Of Dartmouth College |
Vista regulatory T cell mediator protein, vista binding agents and use thereof
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US9115345B2
(en)
|
2010-04-19 |
2015-08-25 |
The Trustees Of The University Of Pennsylvania |
MicroRNA induction of pluripotential stem cells and uses thereof
|
NZ603581A
(en)
|
2010-06-19 |
2015-05-29 |
Sloan Kettering Inst Cancer |
Anti-gd2 antibodies
|
CN107441480A
(zh)
|
2010-06-30 |
2017-12-08 |
卡姆普根有限公司 |
多肽及其作为用于治疗多发性硬化、类风湿性关节炎以及其他自身免疫病症的药物的用途
|
WO2016030888A1
(en)
|
2014-08-26 |
2016-03-03 |
Compugen Ltd. |
Polypeptides and uses thereof as a drug for treatment of autoimmune disorders
|
JP2013541938A
(ja)
|
2010-09-02 |
2013-11-21 |
プロビオドルグ エージー |
アイソqc関連障害の治療のためのインビボスクリーニングモデル
|
US9632088B2
(en)
|
2010-09-07 |
2017-04-25 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for gamma-secretase assay
|
WO2012046238A2
(en)
|
2010-10-06 |
2012-04-12 |
Ramot At Tel-Aviv University Ltd. |
Erythropoietin receptor antagonists
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
WO2012064743A2
(en)
|
2010-11-08 |
2012-05-18 |
The Johns Hopkins University |
Methods for improving heart function
|
AR083885A1
(es)
|
2010-11-15 |
2013-03-27 |
Univ Ramot |
Analogos de dipeptidos para el tratamiento de afecciones asociadas con la formacion de fibrillas amiloides
|
RS57502B1
(sr)
|
2010-11-23 |
2018-10-31 |
Glaxo Group Ltd |
Antigen-vezujući proteini za onkostatin m (osm)
|
EP2643351A1
(de)
|
2010-11-24 |
2013-10-02 |
Glaxo Group Limited |
Auf hgf abzielende multispezifische antigenbindende proteine
|
MX344595B
(es)
|
2010-12-31 |
2016-12-20 |
Bioatla Llc |
Humanizacion rapida de anticuerpos.
|
US9956236B2
(en)
|
2011-02-07 |
2018-05-01 |
Cornell University |
Methods for increasing immune responses using agents that directly bind to and activate IRE-1
|
US8974782B2
(en)
|
2011-02-07 |
2015-03-10 |
Glaxo Group Limited |
Treatment of stroke comprising anti-MAG antibodies
|
CN102643852B
(zh)
|
2011-02-28 |
2015-04-08 |
华东理工大学 |
光可控的基因表达系统
|
WO2012140627A1
(en)
|
2011-04-15 |
2012-10-18 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
|
EP3378954B1
(de)
|
2011-04-29 |
2021-02-17 |
Sequenom, Inc. |
Quantifizierung einer minderheitsvariante einer nukleinsäure
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
ES2931180T3
(es)
|
2011-05-19 |
2022-12-27 |
Fund Publica Andaluza Progreso Y Salud |
Sistema de tipo Tet-on lentivírico de promotor dual muy inducible
|
EP2714741B1
(de)
|
2011-05-25 |
2019-10-30 |
Innate Pharma, S.A. |
Anti-kir-antikörper zur behandlung entzündlicher erkrankungen
|
PT3415531T
(pt)
|
2011-05-27 |
2023-09-12 |
Glaxo Group Ltd |
Proteínas de ligação a bcma (cd269/tnfrsf17
|
AU2012277376B2
(en)
|
2011-06-30 |
2016-11-24 |
Compugen Ltd. |
Polypeptides and uses thereof for treatment of autoimmune disorders and infection
|
CA2842099A1
(en)
|
2011-07-27 |
2013-01-31 |
Glaxo Group Limited |
Antigen binding constructs
|
WO2013024043A2
(en)
|
2011-08-12 |
2013-02-21 |
Probiodrug Ag |
In vivo screening models for treatment of qc-related disorders
|
DK2748192T3
(en)
|
2011-08-23 |
2019-02-25 |
Found Medicine Inc |
KIF5B-RET-FUSION MOLECULES AND APPLICATIONS THEREOF
|
WO2013039996A1
(en)
|
2011-09-13 |
2013-03-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using fndc5
|
WO2013055911A1
(en)
|
2011-10-14 |
2013-04-18 |
Dana-Farber Cancer Institute, Inc. |
Znf365/zfp365 biomarker predictive of anti-cancer response
|
EP2785370B1
(de)
|
2011-12-02 |
2021-07-21 |
Rhode Island Hospital |
Impfstoff gegen falciparum-malaria
|
CA2855570A1
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
US10118958B2
(en)
|
2011-12-14 |
2018-11-06 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
EP2793936A4
(de)
*
|
2011-12-19 |
2015-05-27 |
Lfb Usa Inc |
Rekombinantes menschliches alpha-1-antitrypsin zur behandlung von entzündungskrankheiten
|
MY176695A
(en)
|
2012-01-27 |
2020-08-19 |
Abbvie Inc |
Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
AU2013216320A1
(en)
|
2012-02-01 |
2014-04-03 |
Compugen Ltd. |
C10RF32 antibodies, and uses thereof for treatment of cancer
|
ES2676029T3
(es)
|
2012-02-09 |
2018-07-16 |
Var2 Pharmaceuticals Aps |
Direccionamiento de glicanos de sulfato de condroitina
|
ES2855133T3
(es)
|
2012-02-14 |
2021-09-23 |
Opko Biologics Ltd |
Factores de coagulación de acción prolongada y usos de los mismos
|
PT2814844T
(pt)
|
2012-02-15 |
2017-09-18 |
Novo Nordisk As |
Anticorpos que se ligam e bloqueiam recetor de acionamento expresso em células mieloides-1 (trem-1)
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
SI2814842T1
(sl)
|
2012-02-15 |
2018-10-30 |
Novo Nordisk A/S |
Protitelesa, ki vežejo peptidoglikal prepoznan protein 1
|
EP4155401A1
(de)
|
2012-03-02 |
2023-03-29 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
JP6200437B2
(ja)
|
2012-03-16 |
2017-09-20 |
ユニバーシティ ヘルス ネットワーク |
Toso活性を調節するための方法および組成物
|
US9494597B2
(en)
|
2012-04-02 |
2016-11-15 |
Ab Biosciences, Inc. |
Human control antibodies and uses therefor
|
MY167814A
(en)
|
2012-04-19 |
2018-09-26 |
Opko Biologics Ltd |
Long-acting oxyntomodulin variants and methods of producing same
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
CN104603149B
(zh)
|
2012-05-24 |
2017-06-30 |
万机集团有限公司 |
与预防和治疗狂犬病感染相关的组合物和方法
|
FI3421486T3
(fi)
|
2012-06-22 |
2023-12-15 |
Dartmouth College |
Uusia vista-ig-rakenteita ja vista-ig:n käyttö autoimmuuni-, allergia- ja tulehdushäiriöiden hoitamiseksi
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
WO2014039983A1
(en)
|
2012-09-07 |
2014-03-13 |
The Trustees Of Dartmouth College |
Vista modulators for diagnosis and treatment of cancer
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US9511087B2
(en)
|
2012-08-03 |
2016-12-06 |
Revo Biologics, Inc. |
Use of antithrombin in extracorporeal membrane oxygenation
|
EP2888279A1
(de)
|
2012-08-22 |
2015-07-01 |
Glaxo Group Limited |
Anti-lrp6-antikörper
|
WO2014060401A1
(en)
|
2012-10-15 |
2014-04-24 |
Novo Nordisk Health Care Ag |
Coagulation factor vii polypeptides
|
US9657076B2
(en)
|
2012-10-23 |
2017-05-23 |
Emory University |
GM-CSF and IL-4 conjugates, compositions, and methods related thereto
|
CA2890207A1
(en)
|
2012-11-05 |
2014-05-08 |
Foundation Medicine, Inc. |
Novel ntrk1 fusion molecules and uses thereof
|
CA2891393A1
(en)
|
2012-11-20 |
2014-05-30 |
Opko Biologics Ltd. |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
JP6552965B2
(ja)
|
2012-12-12 |
2019-07-31 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
配列操作のための改善された系、方法および酵素組成物のエンジニアリングおよび最適化
|
ES2576128T3
(es)
|
2012-12-12 |
2016-07-05 |
The Broad Institute, Inc. |
Modificación por tecnología genética y optimización de sistemas, métodos y composiciones para la manipulación de secuencias con dominios funcionales
|
EP2932421A1
(de)
|
2012-12-12 |
2015-10-21 |
The Broad Institute, Inc. |
Verfahren, systeme und vorrichtung zur identifizierung von zielsequenzen für cas-enzyme oder crispr-cas-systeme für zielsequenzen und ergebnisübermittlung
|
US20140310830A1
(en)
|
2012-12-12 |
2014-10-16 |
Feng Zhang |
CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes
|
ES2701749T3
(es)
|
2012-12-12 |
2019-02-25 |
Broad Inst Inc |
Métodos, modelos, sistemas y aparatos para identificar secuencias diana para enzimas Cas o sistemas CRISPR-Cas para secuencias diana y transmitir resultados de los mismos
|
CN113528577A
(zh)
|
2012-12-12 |
2021-10-22 |
布罗德研究所有限公司 |
用于序列操纵的系统、方法和优化的指导组合物的工程化
|
EP4234696A3
(de)
|
2012-12-12 |
2023-09-06 |
The Broad Institute Inc. |
Systeme, verfahren und zusammensetzungen mit crispr-cas-komponenten zur sequenzmanipulation
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
ES2883590T3
(es)
|
2012-12-12 |
2021-12-09 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas, métodos y composiciones para la manipulación de secuencias y aplicaciones terapéuticas
|
EP2931899A1
(de)
|
2012-12-12 |
2015-10-21 |
The Broad Institute, Inc. |
Funktionale genomik unter verwendung von crispr-cas systemen, zusammensetzungen, verfahren, knockout-bibliotheken und anwendungen davon
|
CA3150658A1
(en)
|
2013-01-18 |
2014-07-24 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
US20160002294A1
(en)
|
2013-01-28 |
2016-01-07 |
Solae, Llc |
Novel polypeptides having satiety hormone releasing activity
|
BR112015019348A2
(pt)
|
2013-02-13 |
2017-08-22 |
Lab Francais Du Fractionnement |
Métodos para produção de proteína com glicosilação modificada e com sialilação aumentada, para aumentar a atividade de sialil transferase na glândula mamária e para produzir sialil transferase, proteína com glicosilação modificada ou proteína com sialilação aumentada, composição, sialil transferase, mamífero transgênico, e, célula epitelial mamária
|
EP2956480B1
(de)
|
2013-02-13 |
2019-09-04 |
Laboratoire Français du Fractionnement et des Biotechnologies |
In hohem masse galactosylierte anti-tnf-alpha-antikörper und verwendungen davon
|
WO2014168711A1
(en)
|
2013-03-13 |
2014-10-16 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
AU2014230741B2
(en)
|
2013-03-15 |
2017-04-13 |
Glaxosmithkline Intellectual Property Development Limited |
Anti-LAG-3 binding proteins
|
KR102207859B1
(ko)
|
2013-03-15 |
2021-01-27 |
메모리얼 슬로안 케터링 캔서 센터 |
고 친화도 항-gd2 항체
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
ES2753419T3
(es)
|
2013-06-07 |
2020-04-08 |
Univ Duke |
Inhibidores del factor H del complemento
|
CN105793425B
(zh)
|
2013-06-17 |
2021-10-26 |
布罗德研究所有限公司 |
使用病毒组分靶向障碍和疾病的crispr-cas系统和组合物的递送、用途和治疗应用
|
CN105492611A
(zh)
|
2013-06-17 |
2016-04-13 |
布罗德研究所有限公司 |
用于序列操纵的优化的crispr-cas双切口酶系统、方法以及组合物
|
EP3725885A1
(de)
|
2013-06-17 |
2020-10-21 |
The Broad Institute, Inc. |
Funktionale genomik unter verwendung von crispr-cas-systemen, zusammensetzungen, verfahren, schirme und anwendungen davon
|
RU2725502C2
(ru)
|
2013-06-17 |
2020-07-02 |
Те Брод Инститьют Инк. |
Доставка, конструирование и оптимизация систем, способы и композиции для целенаправленного воздействия и моделирования заболеваний и нарушений постмитотических клеток
|
CA2915834A1
(en)
|
2013-06-17 |
2014-12-24 |
Massachusetts Institute Of Technology |
Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
|
RU2716420C2
(ru)
|
2013-06-17 |
2020-03-11 |
Те Брод Инститьют Инк. |
Доставка и применение систем crispr-cas, векторов и композиций для целенаправленного воздействия и терапии в печени
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
DK3049521T3
(en)
|
2013-09-25 |
2019-04-23 |
Univ Cornell |
Compounds for inducing antitumor immunity and methods thereof
|
EP3060239B1
(de)
|
2013-10-21 |
2020-05-13 |
OPKO Biologics Ltd. |
Polypeptide mit langzeitwirkung sowie verfahren zur herstellung und verabreichung davon
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
WO2015065964A1
(en)
|
2013-10-28 |
2015-05-07 |
The Broad Institute Inc. |
Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof
|
EP2876114A1
(de)
|
2013-11-25 |
2015-05-27 |
Consejo Superior De Investigaciones Científicas |
Antikörper gegen CCR9 und Anwendungen davon
|
BR112016013207A2
(pt)
|
2013-12-12 |
2017-09-26 |
Massachusetts Inst Technology |
administração, uso e aplicações terapêuticas dos sistemas crispr-cas e composições para o hbv e distúrbios e doenças virais
|
AU2014361781B2
(en)
|
2013-12-12 |
2021-04-01 |
Massachusetts Institute Of Technology |
Delivery, use and therapeutic applications of the CRISPR -Cas systems and compositions for genome editing
|
MX2016007327A
(es)
|
2013-12-12 |
2017-03-06 |
Broad Inst Inc |
Suministro, uso y aplicaciones terapeuticas de sistemas y composiciones crispr-cas para dirigirlos a trastornos y enfermedades usando componentes para suministro de particulas.
|
JP6712948B2
(ja)
|
2013-12-12 |
2020-06-24 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
組成物、及びヌクレオチドリピート障害におけるcrispr−cas系の使用方法
|
WO2015089473A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
|
WO2015089486A2
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
PL3712174T3
(pl)
|
2013-12-24 |
2022-07-04 |
Janssen Pharmaceutica Nv |
Przeciwciała i fragmenty anty-vista
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
CA2936285A1
(en)
|
2014-02-07 |
2015-08-13 |
Medimmune, Llc |
Novel assay to detect human periostin
|
AU2015225867B2
(en)
|
2014-03-07 |
2020-02-06 |
University Health Network |
Methods and compositions for modifying the immune response
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
US11624093B2
(en)
|
2014-04-24 |
2023-04-11 |
Dana-Farber Cancer Institute, Inc. |
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
|
DK3143134T3
(da)
|
2014-05-15 |
2021-01-04 |
Nat Univ Singapore |
Modificerede, naturlige dræberceller og anvendelser deraf
|
PT3143123T
(pt)
|
2014-05-16 |
2020-02-04 |
Univ Pennsylvania |
Indução da regeneração cardíaca por micro-rna
|
MX2016016310A
(es)
|
2014-06-11 |
2017-10-20 |
A Green Kathy |
Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
|
MX2016016833A
(es)
|
2014-06-16 |
2017-10-04 |
Univ Johns Hopkins |
Composiciones y metodos para la expresion de arns guias crispr que usan el promotor h1.
|
MY178347A
(en)
|
2014-07-17 |
2020-10-08 |
Novo Nordisk As |
Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
WO2016028682A1
(en)
|
2014-08-17 |
2016-02-25 |
The Broad Institute Inc. |
Genome editing using cas9 nickases
|
WO2016049024A2
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling competition of multiple cancer mutations in vivo
|
WO2016049163A2
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Use and production of chd8+/- transgenic animals with behavioral phenotypes characteristic of autism spectrum disorder
|
WO2016049251A1
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling mutations in leukocytes
|
WO2016049258A2
(en)
|
2014-09-25 |
2016-03-31 |
The Broad Institute Inc. |
Functional screening with optimized functional crispr-cas systems
|
AU2015328411C1
(en)
|
2014-10-06 |
2022-03-03 |
Dana-Farber Cancer Institute, Inc. |
Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response
|
EP3226900A4
(de)
|
2014-12-05 |
2018-09-19 |
Immunext, Inc. |
Identifizierung von vsig8 als vermeintlicher vista-rezeptor und dessen verwendung zur herstellung von vista/vsig8-modulatoren
|
US20180111974A1
(en)
|
2014-12-10 |
2018-04-26 |
Opko Biologics Ltd. |
Methods of producing long acting ctp-modified growth hormone polypeptides
|
EP3230452A1
(de)
|
2014-12-12 |
2017-10-18 |
The Broad Institute Inc. |
Totführungen für crispr-transkriptionsfaktoren
|
EP3985115A1
(de)
|
2014-12-12 |
2022-04-20 |
The Broad Institute, Inc. |
Geschützte guide-rnas (pgrnas)
|
WO2016094874A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Escorted and functionalized guides for crispr-cas systems
|
WO2016094880A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of crispr systems and compositions for genome editing as to hematopoietic stem cells (hscs)
|
WO2016100974A1
(en)
|
2014-12-19 |
2016-06-23 |
The Broad Institute Inc. |
Unbiased identification of double-strand breaks and genomic rearrangement by genome-wide insert capture sequencing
|
WO2016106236A1
(en)
|
2014-12-23 |
2016-06-30 |
The Broad Institute Inc. |
Rna-targeting system
|
WO2016106244A1
(en)
|
2014-12-24 |
2016-06-30 |
The Broad Institute Inc. |
Crispr having or associated with destabilization domains
|
WO2016108926A1
(en)
|
2014-12-30 |
2016-07-07 |
The Broad Institute Inc. |
Crispr mediated in vivo modeling and genetic screening of tumor growth and metastasis
|
MA41296A
(fr)
|
2014-12-30 |
2017-11-07 |
Orgenesis Ltd |
Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
|
EP3265825A4
(de)
|
2015-03-06 |
2018-08-08 |
Dana-Farber Cancer Institute, Inc. |
Pd-l2-biomarker zur vorhersage von pd-1-weg-inhibitor-reaktionen bei ösophagogastrischem krebs
|
WO2016149368A1
(en)
|
2015-03-17 |
2016-09-22 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16 antibodies and uses thereof
|
US20180064748A1
(en)
|
2015-03-27 |
2018-03-08 |
Yeda Research And Development Co. Ltd. |
Methods of treating motor neuron diseases
|
US20180161300A1
(en)
|
2015-05-11 |
2018-06-14 |
Yeda Research And Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016205728A1
(en)
|
2015-06-17 |
2016-12-22 |
Massachusetts Institute Of Technology |
Crispr mediated recording of cellular events
|
WO2016205749A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
FI3430134T3
(fi)
|
2015-06-18 |
2023-01-13 |
|
Uusia CRISPR-entsyymejä ja järjestelmiä
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
WO2016205745A2
(en)
*
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Cell sorting
|
CN108289851B
(zh)
|
2015-06-19 |
2021-06-01 |
Opko生物科学有限公司 |
长效凝固因子及其产生方法
|
JP7026509B2
(ja)
|
2015-06-24 |
2022-02-28 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体およびフラグメント
|
US10287338B2
(en)
|
2015-07-10 |
2019-05-14 |
Miran NERSISSIAN |
Factor VIII protein compositions and methods of treating of hemophilia A
|
WO2017023863A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
WO2017024317A2
(en)
|
2015-08-06 |
2017-02-09 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
WO2017025963A1
(en)
|
2015-08-10 |
2017-02-16 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using cd24
|
EP3798234A1
(de)
|
2015-09-02 |
2021-03-31 |
Immutep S.A.S. |
Agonistische anti-lag-3 antikörper
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
CA3024543A1
(en)
|
2015-10-22 |
2017-04-27 |
The Broad Institute, Inc. |
Type vi-b crispr enzymes and systems
|
JP7109784B2
(ja)
|
2015-10-23 |
2022-08-01 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
遺伝子編集のための進化したCas9蛋白質
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
WO2017081686A1
(en)
|
2015-11-10 |
2017-05-18 |
B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University |
Means and methods for reducing tumorigenicity of cancer stem cells
|
US20190233814A1
(en)
|
2015-12-18 |
2019-08-01 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
US10465003B2
(en)
|
2016-02-05 |
2019-11-05 |
Janssen Biotech, Inc. |
Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
|
CN116920085A
(zh)
|
2016-02-12 |
2023-10-24 |
詹森药业有限公司 |
抗-vista(b7h5)抗体
|
WO2017138008A2
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
AU2017241776A1
(en)
|
2016-03-29 |
2018-10-11 |
Janssen Biotech, Inc. |
Treating psoriasis with increased interval dosing of anti-IL12 and/or -23 antibody
|
US20190083642A1
(en)
|
2016-03-30 |
2019-03-21 |
Regentis Biomaterials Ltd. |
Treatments utilizing a polymer-protein conjugate
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
RU2021111187A
(ru)
|
2016-04-15 |
2021-04-29 |
Янссен Фармасьютикалз, Инк. |
Антитела против человеческого vista и их применение
|
KR102424476B1
(ko)
|
2016-04-19 |
2022-07-25 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신규한 crispr 효소 및 시스템
|
AU2017253107B2
(en)
|
2016-04-19 |
2023-07-20 |
Massachusetts Institute Of Technology |
CPF1 complexes with reduced indel activity
|
WO2018229521A1
(en)
|
2016-06-16 |
2018-12-20 |
Oslo Universitetssykehus Hf |
Improved gene editing
|
EP3455357A1
(de)
|
2016-06-17 |
2019-03-20 |
The Broad Institute Inc. |
Typ-vi-crispr-orthologe und systeme
|
WO2018005873A1
(en)
|
2016-06-29 |
2018-01-04 |
The Broad Institute Inc. |
Crispr-cas systems having destabilization domain
|
CN109844116A
(zh)
|
2016-07-05 |
2019-06-04 |
约翰霍普金斯大学 |
包括使用h1启动子对crispr指导rna的改进的组合物和方法
|
US11141463B2
(en)
|
2016-07-11 |
2021-10-12 |
The National Institute for Biotechnology in the Negev Ltd. |
Fusion proteins with extended serum half life
|
KR102618424B1
(ko)
|
2016-07-11 |
2023-12-26 |
옵코 바이오로직스 리미티드 |
지속성 응고 인자 vii 및 그 제조 방법
|
US11603533B2
(en)
|
2016-07-12 |
2023-03-14 |
Washington University |
Incorporation of internal polya-encoded poly-lysine sequence tags and their variations for the tunable control of protein synthesis in bacterial and eukaryotic cells
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
WO2018035388A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
US20200283743A1
(en)
|
2016-08-17 |
2020-09-10 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
WO2018047154A1
(en)
|
2016-09-07 |
2018-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anti-nkp46 antibodies and therapeutic use of same
|
JP7466308B2
(ja)
|
2016-09-20 |
2024-04-12 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Usp10バイオマーカーおよびモジュレーターを用いたamlの同定、評価、予防および処置のための組成物および方法
|
MX2019003703A
(es)
|
2016-09-30 |
2020-08-13 |
Janssen Biotech Inc |
Método seguro y eficaz para tratar la psoriasis con el anticuerpo específico anti-il23.
|
EP3519824A1
(de)
|
2016-10-03 |
2019-08-07 |
Abbott Laboratories |
Verbesserte verfahren zur beurteilung des uch-l1-status in patientenproben
|
WO2018071868A1
(en)
|
2016-10-14 |
2018-04-19 |
President And Fellows Of Harvard College |
Aav delivery of nucleobase editors
|
WO2018074979A1
(en)
|
2016-10-17 |
2018-04-26 |
Nanyang Technological University |
Truncated crispr-cas proteins for dna targeting
|
AU2017362222A1
(en)
|
2016-11-16 |
2019-05-30 |
Janssen Biotech, Inc. |
Method of treating psoriasis with anti-IL-23 specific antibody
|
JP2019535298A
(ja)
|
2016-11-28 |
2019-12-12 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
単離ポリヌクレオチドおよびポリペプチドおよび関心のある発現産物を発現させるためにそれらを使用する方法
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
CA3049114A1
(en)
|
2017-01-04 |
2018-07-12 |
Lauren O. Bakaletz |
Antibody fragments for the treatment of biofilm-related disorders
|
CA3049105A1
(en)
|
2017-01-04 |
2018-07-12 |
Lauren O. Bakaletz |
Dnabii vaccines and antibodies with enhanced activity
|
US11702458B2
(en)
|
2017-01-05 |
2023-07-18 |
Kahr Medical Ltd. |
PD1-41BBL fusion protein and methods of use thereof
|
SI3565828T1
(sl)
|
2017-01-05 |
2022-04-29 |
Kahr Medical Ltd. |
SIRP1 alfa-41BBL fuzijski protein in postopki za njegovo uporabo
|
EP3574012A1
(de)
|
2017-01-27 |
2019-12-04 |
Memorial Sloan Kettering Cancer Center |
Bispezifische her2- und cd3-bindende moleküle
|
CA3052095A1
(en)
|
2017-01-30 |
2018-08-02 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis
|
MA47442A
(fr)
|
2017-02-07 |
2019-12-18 |
Janssen Biotech Inc |
Anticorps anti-tnf, compositions et méthodes pour le traitement de la spondylarthrite ankylosante active
|
WO2018165504A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
KR20190127797A
(ko)
|
2017-03-10 |
2019-11-13 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
시토신에서 구아닌으로의 염기 편집제
|
KR102185464B1
(ko)
|
2017-03-15 |
2020-12-03 |
매사추세츠 인스티튜트 오브 테크놀로지 |
신규 cas13b 오르소로그 crispr 효소 및 시스템
|
CA3056088A1
(en)
|
2017-03-15 |
2018-09-20 |
Research Institute At Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
CA3057192A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
US11016092B2
(en)
|
2017-03-23 |
2021-05-25 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1
|
WO2018191388A1
(en)
|
2017-04-12 |
2018-10-18 |
The Broad Institute, Inc. |
Novel type vi crispr orthologs and systems
|
US10877048B2
(en)
|
2017-04-15 |
2020-12-29 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
US10877038B2
(en)
|
2017-04-28 |
2020-12-29 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
EP3635106A4
(de)
|
2017-05-08 |
2021-01-06 |
Orgenesis Ltd. |
Transdifferenzierte zellpopulationen und verfahren zur verwendung davon
|
WO2018208910A1
(en)
|
2017-05-09 |
2018-11-15 |
The Broad Institute Inc. |
Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
AU2018272054A1
(en)
|
2017-05-25 |
2019-09-26 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
JP7269183B2
(ja)
|
2017-05-30 |
2023-05-08 |
アボット・ラボラトリーズ |
心臓トロポニンiを使用する、ヒト対象における軽度外傷性脳損傷を診断及び査定する一助となるための方法
|
WO2018226685A2
(en)
|
2017-06-06 |
2018-12-13 |
Dana-Farber Cancer Institute, Inc. |
Methods for sensitizing cancer cells to t cell-mediated killing by modulating molecular pathways
|
CN111328290A
(zh)
|
2017-06-26 |
2020-06-23 |
博德研究所 |
用于靶向核酸编辑的基于crispr/cas-腺嘌呤脱氨酶的组合物、系统和方法
|
WO2019010131A1
(en)
|
2017-07-03 |
2019-01-10 |
Abbott Laboratories |
IMPROVED METHODS FOR MEASURING CARBOXY TERMINATION HYDROLASE LEVELS OF UBIQUITIN L1 IN BLOOD
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
AU2018338318B2
(en)
|
2017-09-21 |
2022-12-22 |
Massachusetts Institute Of Technology |
Systems, methods, and compositions for targeted nucleic acid editing
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
CA3082251A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
US11547614B2
(en)
|
2017-10-31 |
2023-01-10 |
The Broad Institute, Inc. |
Methods and compositions for studying cell evolution
|
WO2019094595A2
(en)
|
2017-11-09 |
2019-05-16 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
EP3710039A4
(de)
|
2017-11-13 |
2021-08-04 |
The Broad Institute, Inc. |
Verfahren und zusammensetzungen zur behandlung von krebs durch targeting des clec2d-klrb1-wegs
|
US11022617B2
(en)
|
2017-12-09 |
2021-06-01 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)
|
BR112020010085A2
(pt)
|
2017-12-09 |
2020-10-13 |
Abbott Laboratories |
métodos para auxiliar no diagnóstico e avaliar uma lesão cerebral traumática em um indivíduo humano usando uma combinação de gfap e uch-l1
|
JP7437303B2
(ja)
|
2017-12-29 |
2024-02-22 |
アボット・ラボラトリーズ |
外傷性脳損傷を診断及び査定するための、新規のバイオマーカー及び方法
|
WO2019150309A1
(en)
|
2018-02-02 |
2019-08-08 |
Hammack Scott |
Modulators of gpr68 and uses thereof for treating and preventing diseases
|
JP2021515770A
(ja)
|
2018-03-05 |
2021-06-24 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il−23特異的抗体を用いたクローン病の治療方法
|
CA3093694A1
(en)
|
2018-03-12 |
2019-09-19 |
Memorial Sloan Kettering Cancer Center |
Bispecific binding agents and uses thereof
|
US11155618B2
(en)
|
2018-04-02 |
2021-10-26 |
Bristol-Myers Squibb Company |
Anti-TREM-1 antibodies and uses thereof
|
US10968257B2
(en)
|
2018-04-03 |
2021-04-06 |
The Broad Institute, Inc. |
Target recognition motifs and uses thereof
|
WO2019209807A1
(en)
|
2018-04-23 |
2019-10-31 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for modulating endoplasmic reticulum-associated degradation
|
WO2019211842A1
(en)
|
2018-04-30 |
2019-11-07 |
Opko Biologics Ltd. |
Long-acting human growth hormone-antagonists and methods of producing the same
|
WO2019213619A1
(en)
|
2018-05-04 |
2019-11-07 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
US20190345245A1
(en)
|
2018-05-11 |
2019-11-14 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
US20210198330A1
(en)
|
2018-05-23 |
2021-07-01 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
WO2019244107A1
(en)
|
2018-06-21 |
2019-12-26 |
Daiichi Sankyo Company, Limited |
Compositions including cd3 antigen binding fragments and uses thereof
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
MX2021000263A
(es)
|
2018-07-11 |
2021-05-12 |
Kahr Medical Ltd |
Proteina de fusion variante sirpalfa-4-1bbl y procedimientos de uso de la misma.
|
EP3821244A1
(de)
|
2018-07-13 |
2021-05-19 |
Varct Diagnostics ApS |
Isolierung von zirkulierenden zellen fetalen ursprungs unter verwendung von rekombinantem malaria-protein var2csa
|
WO2020016838A2
(en)
|
2018-07-18 |
2020-01-23 |
Janssen Biotech, Inc. |
Sustained response predictors after treatment with anti-il23 specific antibody
|
JP2021532815A
(ja)
|
2018-08-07 |
2021-12-02 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
新規Cas12b酵素およびシステム
|
US20210317429A1
(en)
|
2018-08-20 |
2021-10-14 |
The Broad Institute, Inc. |
Methods and compositions for optochemical control of crispr-cas9
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
DK3883606T5
(da)
|
2018-09-24 |
2024-01-02 |
Janssen Biotech Inc |
Sikker og effektiv fremgangsmåde til behandling af colitis ulcerosa med anti-il12/il23-antistof
|
JP2022512580A
(ja)
|
2018-10-05 |
2022-02-07 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
細菌バイオフィルムの酵素的破壊のための組成物および方法
|
WO2020086627A1
(en)
|
2018-10-22 |
2020-04-30 |
University Of Rochester |
Genome editing by directed non-homologous dna insertion using a retroviral integrase-cas9 fusion protein
|
CA3117961A1
(en)
|
2018-10-29 |
2020-05-07 |
Spin Therapeutics, Llc |
Compositions and methods for alpha-1-antitrypsin disorders
|
WO2020102659A1
(en)
|
2018-11-15 |
2020-05-22 |
The Broad Institute, Inc. |
G-to-t base editors and uses thereof
|
WO2020104943A2
(en)
|
2018-11-20 |
2020-05-28 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-il-23 specific antibody
|
US20200197517A1
(en)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
|
KR20210126014A
(ko)
|
2019-01-14 |
2021-10-19 |
유니버시티 오브 로체스터 |
CRISPR-Cas로 표적화된 핵 RNA 분열 및 폴리아데닐화
|
BR112021013903A2
(pt)
|
2019-01-15 |
2021-09-21 |
Janssen Biotech, Inc. |
Composições e métodos de anticorpos anti-tnf para o tratamento da artrite idiopática juvenil
|
WO2020152544A1
(en)
|
2019-01-23 |
2020-07-30 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
|
WO2020181193A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenosine methylation
|
WO2020181178A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through thymine alkylation
|
WO2020181195A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenine excision
|
WO2020181202A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to t:a base editing through adenine deamination and oxidation
|
WO2020181180A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to c:g base editors and uses thereof
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
JP2022525145A
(ja)
|
2019-03-14 |
2022-05-11 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il12/il23抗体組成物を生成するための製造方法
|
EP3938392A1
(de)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Verfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
CN113840838A
(zh)
|
2019-03-14 |
2021-12-24 |
詹森生物科技公司 |
用于产生抗tnf抗体组合物的制造方法
|
EP3938391A1
(de)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Verfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
US20220177863A1
(en)
|
2019-03-18 |
2022-06-09 |
The Broad Institute, Inc. |
Type vii crispr proteins and systems
|
KR20210141583A
(ko)
|
2019-03-18 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-il-12/il-23 항체를 사용한 소아 대상의 건선 치료 방법
|
MX2021011426A
(es)
|
2019-03-19 |
2022-03-11 |
Broad Inst Inc |
Metodos y composiciones para editar secuencias de nucleótidos.
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
EP3969026A1
(de)
|
2019-05-16 |
2022-03-23 |
Ceva Santé Animale |
Zusammensetzungen und verfahren zur erhöhung der reproduktionsleistung bei nichtmenschlichen säugetieren unter verwendung des rekombinanten luteinisierenden hormons
|
US20220220469A1
(en)
|
2019-05-20 |
2022-07-14 |
The Broad Institute, Inc. |
Non-class i multi-component nucleic acid targeting systems
|
JP2022534020A
(ja)
|
2019-05-23 |
2022-07-27 |
ヤンセン バイオテツク,インコーポレーテツド |
Il-23及びtnfアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
|
EP3976648A1
(de)
|
2019-06-03 |
2022-04-06 |
Janssen Biotech, Inc. |
Anti-tnf-antikörperzusammensetzungen und verfahren zur behandlung von aktiver psoriasis-arthritis
|
MX2021014882A
(es)
|
2019-06-03 |
2022-03-25 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa.
|
CN114222760A
(zh)
|
2019-06-26 |
2022-03-22 |
葛兰素史密斯克莱知识产权发展有限公司 |
Il1rap结合蛋白
|
AU2020311897A1
(en)
|
2019-07-08 |
2022-02-03 |
Research Institute At Nationwide Children's Hospital |
Antibody compositions for disrupting biofilms
|
WO2021005604A1
(en)
|
2019-07-11 |
2021-01-14 |
Opko Biologics Ltd. |
Long-acting igf-1 or igf-1 variants and methods of producing same
|
MX2022000367A
(es)
|
2019-07-11 |
2022-07-13 |
Kahr Medical Ltd |
Heterodimeros, metodos y uso de los mismos.
|
JP2022544015A
(ja)
|
2019-07-23 |
2022-10-17 |
ユニバーシティ オブ ロチェスター |
CRISPR-Casでの標的化されたRNA切断
|
WO2021030666A1
(en)
|
2019-08-15 |
2021-02-18 |
The Broad Institute, Inc. |
Base editing by transglycosylation
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
CN114729384A
(zh)
|
2019-09-12 |
2022-07-08 |
博德研究所 |
工程化腺相关病毒衣壳
|
JP2023500896A
(ja)
|
2019-11-05 |
2023-01-11 |
ヴァーシティ ブラッド リサーチ インスティテュート ファウンデーション, インコーポレイテッド |
胎児/新生児同種抗体血小板減少症のマウスモデル
|
US11266129B2
(en)
|
2019-11-05 |
2022-03-08 |
Versiti Blood Research Institute Foundation, Inc. |
Murine model of fetal/neonatal alloimmune thrombocytopenia
|
MX2022005678A
(es)
|
2019-11-11 |
2022-10-18 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanocuerpos para el control de insectos y usos de los mismos.
|
WO2021108717A2
(en)
|
2019-11-26 |
2021-06-03 |
The Broad Institute, Inc |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
JP2023507083A
(ja)
|
2019-12-19 |
2023-02-21 |
クイデル コーポレーション |
モノクローナル抗体融合物
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
WO2021158921A2
(en)
|
2020-02-05 |
2021-08-12 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
JP2023519307A
(ja)
|
2020-03-27 |
2023-05-10 |
ユニバーシティ オブ ロチェスター |
Crispr-cas13によるウイルスrnaの標的化破壊
|
WO2021195525A1
(en)
|
2020-03-27 |
2021-09-30 |
University Of Rochester |
Crispr-cas13 crrna arrays
|
WO2021211331A1
(en)
|
2020-04-13 |
2021-10-21 |
Abbott Point Of Care Inc. |
METHODS, COMPLEXES AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF A ß-CORONAVIRUS ANTIBODY IN A SAMPLE
|
IL297761A
(en)
|
2020-05-08 |
2022-12-01 |
Broad Inst Inc |
Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
|
US20230348871A1
(en)
|
2020-07-15 |
2023-11-02 |
University Of Rochester |
Targeted RNA cleavage with dCas13-RNase Fusion Proteins
|
CA3189732A1
(en)
|
2020-07-20 |
2022-01-27 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for treatment and prevention of coronavirus infection
|
US20220043000A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Methods and kits for detecting sars-cov-2 protein in a sample
|
US20230304047A1
(en)
|
2020-08-11 |
2023-09-28 |
University Of Oslo |
Improved gene editing
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
CA3198161A1
(en)
|
2020-12-01 |
2022-06-09 |
Beth MCQUISTON |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
KR20230146521A
(ko)
|
2021-01-13 |
2023-10-19 |
메모리얼 슬로안 케터링 캔서 센터 |
항체-피롤로벤조디아제핀 유도체 접합체
|
US20240115721A1
(en)
|
2021-01-13 |
2024-04-11 |
Memorial Sloan Kettering Cancer Center |
Anti-dll3 antibody-drug conjugate
|
EP4305062A1
(de)
|
2021-03-12 |
2024-01-17 |
Janssen Biotech, Inc. |
Verfahren zur behandlung von patienten mit psoriasisarthritis mit unzureichender reaktion auf eine tnf-therapie mit anti-il23-spezifischem antikörper
|
IL305802A
(en)
|
2021-03-12 |
2023-11-01 |
Janssen Biotech Inc |
A safe and effective method for the treatment of rheumatoid arthritis with a specific anti-IL23 antibody
|
JP2024515715A
(ja)
|
2021-04-23 |
2024-04-10 |
ユニバーシティ オブ ロチェスター |
レトロウイルスインテグラーゼ-Cas融合タンパク質を使用した指向性非相同DNA挿入によるゲノム編集及び治療の方法
|
AU2022279156A1
(en)
|
2021-05-18 |
2023-11-02 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
US20220372129A1
(en)
|
2021-05-20 |
2022-11-24 |
Janssen Biotech, Inc. |
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha
|
WO2022261183A2
(en)
|
2021-06-08 |
2022-12-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
WO2022261509A1
(en)
|
2021-06-11 |
2022-12-15 |
The Broad Institute, Inc. |
Improved cytosine to guanine base editors
|
CA3222291A1
(en)
|
2021-06-14 |
2022-12-22 |
Jaime MARINO |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
US20230042465A1
(en)
|
2021-07-09 |
2023-02-09 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-TNF Antibody Compositions
|
AU2022306973A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
AU2022306144A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
WO2023004367A2
(en)
|
2021-07-20 |
2023-01-26 |
The Broad Institute, Inc. |
Engineered targeting compositions for endothelial cells of the central nervous system vasculature and methods of use thereof
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
WO2023034777A1
(en)
|
2021-08-31 |
2023-03-09 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
AU2022354059A1
(en)
|
2021-09-30 |
2024-03-28 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
WO2023084488A1
(en)
|
2021-11-15 |
2023-05-19 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
WO2023129942A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
WO2023187707A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of treating mild to moderate psoriasis with il-23 specific antibody
|
WO2023196802A1
(en)
|
2022-04-04 |
2023-10-12 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
WO2023223265A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|
WO2023240137A1
(en)
|
2022-06-08 |
2023-12-14 |
The Board Institute, Inc. |
Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
|
WO2024006876A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
WO2024016003A2
(en)
|
2022-07-14 |
2024-01-18 |
The Broad Institute, Inc. |
Aav capsids that enable cns-wide gene delivery through interactions with the transferrin receptor
|
WO2024040083A1
(en)
|
2022-08-16 |
2024-02-22 |
The Broad Institute, Inc. |
Evolved cytosine deaminases and methods of editing dna using same
|
WO2024047587A1
(en)
|
2022-08-31 |
2024-03-07 |
Regel Therapeutics, Inc. |
Cas-phi compositions and methods of use
|
WO2024059692A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
WO2024081245A1
(en)
|
2022-10-10 |
2024-04-18 |
Therapeutics By Design, LLC |
Tissue differentiation factor related polypeptides (tdfrps) for the treatment of myocardial injury
|